Dr Malcolm Starkey from the University of Newcastle and HMRI’s VIVA (Viruses, Infections/Immunity, Vaccines and Asthma) Program has been awarded The Klosterfrau Research Grant 2015 ($A28,300), funding an injection to Dr Starkey’s pulmonary research in children.
“My research is all about understanding why early-life lung infections predispose a child to chronic disease when they’re older,” Dr Starkey said. “That includes asthma and emphysema, or greater susceptibility to the flu virus, but there’s also link with diseases such as type-1 diabetes, Alzheimer’s Disease and arthritis.”
Dr Starkey is aiming to develop new targeted therapies that not only can help a child get better when they’re ill but also improve their long-term health prospects. “It’s preventative and personalised medicine rather than treating patients at the end stage,” Dr Starkey adds.
Thanks, Dr Starkey, for keeping it clever and ensuring Australia doesn’t get left behind.
Dr Malcolm Starkey is an NHMRC early career post-doctoral fellow (Doherty) at the Priority Research Centre for Asthma and Respiratory Diseases. He is a member of Professor Phil Hansbro’s research team based at the Hunter Medical Research Institute.
[img source] Hunter Medical Research Institute